CIK 0001125345
- Non-accelerated filer
- Smaller reporting company
MACROGENICS INC
Sign in to watch- Ticker
- MGNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-251-5172
- Business address
- 9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-20 | Wigginton Jon Marc Sr VP, Clinical Dev. & CMO | Grant or award · Employee stock option (right to buy) | +100,000 | $11.50 | $1.1M | 100,000 |
| 2020-02-20 | Risser Eric Blasius Sr VP & Chief Business Officer | Grant or award · Employee stock option (right to buy) | +90,000 | $11.50 | $1.0M | 90,000 |
| 2020-02-20 | Koenig Scott President and CEO | Grant or award · Employee stock option (right to buy) | +290,000 | $11.50 | $3.3M | 290,000 |
| 2020-02-20 | Peters Jeffrey Stuart General Counsel | Grant or award · Employee stock option (right to buy) | +87,000 | $11.50 | $1.0M | 87,000 |
| 2020-02-20 | Spitznagel Thomas Sr VP, BPD & Manufacturing | Grant or award · Employee stock option (right to buy) | +87,000 | $11.50 | $1.0M | 87,000 |
| 2020-02-20 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion | +500 | $0.94 | $470 | 32,968 |
| 2020-02-20 | Risser Eric Blasius Sr VP & Chief Business Officer | Sale | −500 | $10.84 | $5K | 32,468 |
| 2020-02-20 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion · Employee stock option (right to buy) | −500 | $0.94 | $470 | 6,500 |
| 2020-02-05 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion | +623 | $0.94 | $586 | 33,091 |
| 2020-02-05 | Risser Eric Blasius Sr VP & Chief Business Officer | Sale | −623 | $10.00 | $6K | 32,468 |
| 2020-02-05 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion · Employee stock option (right to buy) | −623 | $0.94 | $586 | 7,000 |
| 2020-02-04 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion | +30 | $0.94 | $28 | 32,498 |
| 2020-02-04 | Risser Eric Blasius Sr VP & Chief Business Officer | Sale | −30 | $10.00 | $300 | 32,468 |
| 2020-02-04 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion · Employee stock option (right to buy) | −30 | $0.94 | $28 | 7,623 |
| 2019-09-27 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion | +1,662 | $0.94 | $2K | 32,468 |
| 2019-09-27 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion · Stock Option (right to buy) | −1,662 | 0 | ||
| 2019-05-22 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion | +1,000 | $0.94 | $940 | 31,806 |
| 2019-05-22 | Risser Eric Blasius Sr VP & Chief Business Officer | Sale | −1,000 | $19.03 | $19K | 30,806 |
| 2019-05-22 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion · Stock Option (right to buy) | −1,000 | 1,662 | ||
| 2019-05-20 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion | +3,000 | $0.94 | $3K | 33,806 |
Page 28 of 35 · 684 trades